Meet the updated Uronext®: now available for children from 7 years old

Cystitis, both acute and chronic, is a common problem affecting a large number of women of different ages. Statistics says that every second woman in Russia has had an episode of acute cystitis at least once in her life, and every sixth has had a chronic manifestation of the disease, as revealed by Konstantin Tevlin, urologist, PhD in Medicine, at the 24th Mother and Child All-Russian Scientific and Educational Forum.

He also noted that lower urinary tract infection is the third most common infection, second only to gastrointestinal tract infections and acute respiratory diseases. According to Konstantin Tevlin, in 80-90% of cases, acute cystitis is caused by E. coli, followed by bacterial colonization and biofilm formation, which antibiotics alone cannot destroy.

Cranberry-based complexes disrupt the formation of biofilms and have an anti-microbial and anti-inflammatory effect. Clinical studies reveal that the risk of urinary tract infection is 26% lower when using a standardized cranberry extract^[1].

Chronic cystitis is very difficult to treat as it seems today, so doctors are focusing on preventive measures that can minimize relapses. For example, dietary supplements such as cranberry or D-mannose may stop recurring cystitis by preventing bacteria from attaching to the urinary tract epithelium^[2].

Uronext^® contains 2000 mg of D-mannose, providing a fourfold reduction in exacerbations of cystitis^[3],[4]. The new composition of Uronext^® presented on the market today includes vitamin D in an increased amount of 500 IU, which will allow patients to boost local immunity and the body’s defenses when fighting against acute cystitis.

In addition, since October, Uronext^® has been approved for children starting from 7 years of age.